What is the pathophysiology of flushing in dengue?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Flushing in Dengue

Flushing in dengue results from virus-induced endothelial activation and cytokine-mediated vasodilation, driven primarily by the host immune response rather than direct viral cytopathic effects.

Primary Mechanism: Immune-Mediated Vascular Changes

The pathophysiology of flushing in dengue is fundamentally a manifestation of endothelial dysfunction triggered by an aberrant immune response 1, 2. The mechanism unfolds through the following cascade:

Viral Infection and Immune Activation

  • Dengue virus primarily infects monocytes, macrophages, and dendritic cells, which become the main source of inflammatory mediators 3, 4
  • The endothelium itself can be directly infected by dengue virus, contributing to both viremia and immune activation 5
  • This dual targeting—both immune cells and endothelial cells—creates a "cytokine storm" characterized by an imbalance between pro-inflammatory and anti-inflammatory mediators 1, 2

Endothelial Activation and Vasodilation

  • Elevated vasoactive cytokines and chemokines induce permeability changes in endothelial cells lining the vasculature 3
  • The endothelium becomes a "battlefield" where immune responses target vascular integrity, leading to functional changes without necessarily causing morphological damage 4
  • These inflammatory mediators cause vasodilation of cutaneous blood vessels, manifesting clinically as flushing 2

Clinical Correlation

  • Flushing typically appears during the febrile phase of dengue, coinciding with peak viremia and cytokine production 6, 7
  • The transient nature of flushing reflects the short-lived effects of biological mediators rather than permanent vascular damage 1
  • Flushing may be accompanied by other cutaneous manifestations including generalized erythematous rash 7

Key Pathophysiologic Mediators

  • Cytokines: The cytokine storm includes both pro-inflammatory mediators that drive vasodilation and anti-inflammatory factors that attempt to restore homeostasis 1, 2
  • Viral NS1 protein: Dengue non-structural protein-1 (NS1) and antibodies against it contribute to endothelial cell dysfunction and may play a role in vascular changes 5
  • Sphingosine kinase-1 and microRNAs: These factors regulate normal vascular function and inflammatory responses, and their dysregulation during dengue infection may affect endothelial cell function 3

Important Clinical Distinction

  • Flushing represents a relatively benign manifestation of endothelial activation, distinct from the more severe vascular permeability changes that characterize dengue hemorrhagic fever or dengue shock syndrome 4, 5
  • While flushing involves vasodilation, severe dengue involves increased vascular permeability with plasma leakage—both mediated by endothelial dysfunction but with different clinical consequences 1, 4

Critical Pitfall to Avoid

Do not confuse flushing with the warning signs of severe dengue progression. While flushing is common and generally benign, persistent vomiting, abdominal pain, mucosal bleeding, lethargy, or restlessness indicate potential progression to severe disease and require immediate medical attention 8.

References

Research

Vascular endothelium: the battlefield of dengue viruses.

FEMS immunology and medical microbiology, 2008

Research

Endothelial dysfunction in dengue virus pathology.

Reviews in medical virology, 2015

Guideline

Dengue Fever Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Clinical Features and Management of Dengue and Zika Virus Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Danger Signs of Dengue

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.